43 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
Jurisdictions that Prevent Inspections 90 PART III Item 10. Directors, Executive Officers and Corporate Governance 91 Item 11. Executive Compensation 91 … electronically with the SEC. A copy of our Corporate Governance Guidelines, Code of Business Conduct and Ethics and the charters of the (i) Audit Committee, (ii
8-K
EX-99.1
dlyw3613onjsd l6
22 Feb 24
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:15am
8-K
0w2i3r0 ttfueiq7ojnx
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
8-K
EX-99.1
87m8r ycxs3ptf1
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
ARS
qxr6uf7
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
kkf4oub2t myxjn7fb
18 Apr 23
Preliminary proxy
7:59am
8-K
EX-99.1
fhog r0ybn6a
4 Aug 22
C4 Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights
8:15am
8-K
35o3bprwhg85a0
2 Aug 22
C4 Therapeutics Appoints Experienced Clinical Development Leaders Laura Bessen, M.D. and Donna Grogan, M.D. to Board of Directors
8:33am
8-K
EX-99.1
e7dicl5k5c8m
5 May 22
C4 Therapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
8:06am